Effector Therapeutics is pioneering the discovery and development of selective translation regulators as a new class of small molecule therapeutics for cancer and other serious diseases.
Type | Private | |
Founded | 2012 | |
HQ | San Diego, CA, US | Map |
Website | effector.com |
Employees (est.) (Jan 2021) | 28 | (+4%) |
Cybersecurity rating | B | More |
Founding Date | 2012 |
Effector Therapeutics total Funding | $101 m |
Effector Therapeutics latest funding size | $16 m |
Time since last funding | 5 years ago |
Effector Therapeutics investors | U.S. Venture Partners (USVP), Osage University Partners, SR One, Novartis Venture Fund, Altitude Life Science Ventures, Astellas Venture Management, Abingworth, The Column Group, Mission Bay Capital, AbbVie Biotech Ventures |
When was Effector Therapeutics founded?
Effector Therapeutics was founded in 2012.
Who are Effector Therapeutics key executives?
Effector Therapeutics's key executives are Larry Lasky, Simeon George and Steve Worland.
How many employees does Effector Therapeutics have?
Effector Therapeutics has 28 employees.
Who are Effector Therapeutics competitors?
Competitors of Effector Therapeutics include Harpoon Therapeutics, Ourotech and Aptevo Therapeutics.
Where is Effector Therapeutics headquarters?
Effector Therapeutics headquarters is located at 11180 Roselle St, San Diego.
Where are Effector Therapeutics offices?
Effector Therapeutics has an office in San Diego.
How many offices does Effector Therapeutics have?
Effector Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies